Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015, Article ID 436807, 11 pages
http://dx.doi.org/10.1155/2015/436807
Research Article

A Novel Pharmacological Method to Study the Chinese Medicinal Formula Hua-Zheng-Hui-Sheng-Dan

1Zhong-Shan-Men Inpatient Department, Tianjin Medical University Cancer Institute and Hospital, National Clinical Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300171, China
2Department of Head and Neck Cancers, West China Hospital, Sichuan University, Chengdu 610041, China
3Chengdu Diao Tianfu Pharmaceutical Group Co., LTD, Chengdu 610041, China

Received 23 April 2015; Revised 10 August 2015; Accepted 16 August 2015

Academic Editor: Shuang-En Chuang

Copyright © 2015 Rui Cao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. X. Wang, A. Zhang, P. Wang et al., “Metabolomics coupled with proteomics advancing drug discovery toward more agile development of targeted combination therapies,” Molecular & Cellular Proteomics, vol. 12, no. 5, pp. 1226–1238, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. A. J. Frew, R. K. Lindemann, B. P. Martin et al., “Combination therapy of established cancer using a histone deacetylase inhibitor and a TRAIL receptor agonist,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 32, pp. 11317–11322, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Wang, G.-B. Zhou, P. Liu et al., “Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 12, pp. 4826–4831, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Zhang, H. Sun, Y. Yuan, W. Sun, G. Jiao, and X. Wang, “An in vivo analysis of the therapeutic and synergistic properties of Chinese medicinal formula Yin-Chen-Hao-Tang based on its active constituents,” Fitoterapia, vol. 82, no. 8, pp. 1160–1168, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. W. Lam, S. Bussom, F. Guan et al., “The four-herb Chinese medicine PHY906 reduces chemotherapy-induced gastrointestinal toxicity,” Science Translational Medicine, vol. 2, no. 45, p. 45ra59, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. L. J. Hofseth and M. J. Wargovich, “Inflammation, cancer, and targets of ginseng,” Journal of Nutrition, vol. 137, no. 1, pp. 183S–185S, 2007. View at Google Scholar · View at Scopus
  7. M. Li, Z. Zhang, D. L. Hill, H. Wang, and R. Zhang, “Curcumin, a dietary component, has anticancer, chemosensitization, and radiosensitization effects by down-regulating the MDM2 oncogene through the PI3K/mTOR/ETS2 pathway,” Cancer Research, vol. 67, no. 5, pp. 1988–1996, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. D. Liu and Z. Chen, “The effects of cantharidin and cantharidin derivates on tumour cells,” Anti-Cancer Agents in Medicinal Chemistry, vol. 9, no. 4, pp. 392–396, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Xiang, Y.-P. Tang, P. Wu, J.-P. Gao, and D.-F. Cai, “Chinese medicine Nao-Shuan-Tong attenuates cerebral ischemic injury by inhibiting apoptosis in a rat model of stroke,” Journal of Ethnopharmacology, vol. 131, no. 1, pp. 174–181, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. Wutang, Wen Bing Tiao Bian, Chinese Medical Ancient Books Publishing House, Beijing, China, 1st edition, 2010.
  11. T.-C. Chou and P. Talalay, “Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors,” Advances in Enzyme Regulation, vol. 22, pp. 27–55, 1984. View at Publisher · View at Google Scholar · View at Scopus
  12. T.-C. Chou, “Drug combination studies and their synergy quantification using the Chou-Talalay method,” Cancer Research, vol. 70, no. 2, pp. 440–446, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. ASI, Taguchi Methods: Implementation Manual, American Supplier Institute (ASI), Dearborn, Mich, USA, 1989.
  14. S. M. Phadke, Quality Engineering Using Robust Design, Prentice Hall, Englewood Cliffs, NJ, USA, 1989.
  15. A. Bendell, “Introduction to Taguchi methodology,” in Taguchi Methods: Proceedings of the 1988 European Conference, Elsevier Applied Science, London, UK, 1988. View at Google Scholar
  16. R. Unal and E. B. Dean, Taguchi Approach to Design Optimization for Quality and Cost: An Overview, NASA, 1990.
  17. H. Liang, J. Tong, G. Xie, J. He, J. Li, and F. Pan, “Synergistic antitumor effect of dichloroacetate in combination with 5-fluorouracil in colorectal cancer,” Journal of Biomedicine and Biotechnology, vol. 2011, Article ID 740564, 7 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. R. K. Tekade and M. B. Chougule, “Formulation development and evaluation of hybrid nanocarrier for cancer therapy: taguchi orthogonal array based design,” BioMed Research International, vol. 2013, Article ID 712678, 18 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Efferth, S. Kahl, K. Paulus et al., “Phytochemistry and pharmacogenomics of natural products derived from traditional Chinese medicine and Chinese materia medica with activity against tumor cells,” Molecular Cancer Therapeutics, vol. 7, no. 1, pp. 152–161, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. Y.-N. Man, X.-H. Liu, and X.-Z. Wu, “Chinese medicine herbal treatment based on syndrome differentiation improves the overall survival of patients with unresectable hepatocellular carcinoma,” Chinese Journal of Integrative Medicine, vol. 21, no. 1, pp. 49–57, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. The Inner Canon of Emperor Huang, Chinese Medical Ancient Books Publishing House, Beijing, China, 2003.
  22. Anonymous, Formularies for 52 Kinds of Disorders, Culture Relics Press, Beijing, China, 1979.
  23. T.-C. Chou, “Preclinical versus clinical drug combination studies,” Leukemia and Lymphoma, vol. 49, no. 11, pp. 2059–2080, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. Z.-C. Yan, D. Chen, X.-Z. Wu, G.-R. Xie, Y. Ba, and Z. Yan, “Effects of aqueous extracts of Aconitum carmichaeli, Rhizoma bolbostemmatis, Phytolacca acinosa, Panax notoginseng and Gekko swinhonis Güenther on Bel-7402 cells,” World Journal of Gastroenterology, vol. 13, no. 19, pp. 2743–2746, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. X.-L. Wang, F. Ma, and X.-Z. Wu, “Anticancer effects of 5-fluorouracil combined with warming and relieving cold phlegm formula on human breast cancer,” Chinese Journal of Integrative Medicine, vol. 18, no. 8, pp. 599–604, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. T. K. Fung and R. Y. C. Poon, “A roller coaster ride with the mitotic cyclins,” Seminars in Cell and Developmental Biology, vol. 16, no. 3, pp. 335–342, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Ogasawara, T. Matsunaga, S. Takahashi, I. Saiki, and H. Suzuki, “Anti-invasive and metastatic activities of evodiamine,” Biological & Pharmaceutical Bulletin, vol. 25, no. 11, pp. 1491–1493, 2002. View at Publisher · View at Google Scholar
  28. J. Yang, L.-J. Wu, S.-I. Tashino, S. Onodera, and T. Ikejima, “Reactive oxygen species and nitric oxide regulate mitochondria-dependent apoptosis and autophagy in evodiamine-treated human cervix carcinoma HeLa cells,” Free Radical Research, vol. 42, no. 5, pp. 492–504, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. W. Cao, X.-Q. Li, X. Wang et al., “A novel polysaccharide, isolated from Angelica sinensis (Oliv.) Diels induces the apoptosis of cervical cancer HeLa cells through an intrinsic apoptotic pathway,” Phytomedicine, vol. 17, no. 8-9, pp. 598–605, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. K. B. Kwon, E. K. Kim, M. J. Han et al., “Induction of apoptosis by Radix Paeoniae Alba extract through cytochrome c release and the activations of caspase-9 and caspase-3 in HL-60 cells,” Biological & Pharmaceutical Bulletin, vol. 29, no. 6, pp. 1082–1086, 2006. View at Publisher · View at Google Scholar
  31. Y.-M. Lee, Y.-C. Kim, B.-J. Choi, D.-W. Lee, J.-H. Yoon, and E.-C. Kim, “Mechanism of sappanchalcone-induced growth inhibition and apoptosis in human oral cancer cells,” Toxicology in Vitro, vol. 25, no. 8, pp. 1782–1788, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. S.-Z. Lin, W.-T. Wei, H. Chen et al., “Antitumor activity of emodin against pancreatic cancer depends on its dual role: promotion of apoptosis and suppression of angiogenesis,” PLoS ONE, vol. 7, no. 8, Article ID e42146, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. W. Yaoxian, Y. Hui, Z. Yunyan, L. Yanqin, G. Xin, and W. Xiaoke, “Emodin induces apoptosis of human cervical cancer hela cells via intrinsic mitochondrial and extrinsic death receptor pathway,” Cancer Cell International, vol. 13, no. 1, article 71, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. H.-G. Lee, K.-A. Yu, W.-K. Oh et al., “Inhibitory effect of jaceosidin isolated from Artemisiaargyi on the function of E6 and E7 oncoproteins of HPV 16,” Journal of Ethnopharmacology, vol. 98, no. 3, pp. 339–343, 2005. View at Publisher · View at Google Scholar · View at Scopus